AGM Statement
Genus PLC
15 November 2007
For Immediate Release 15 November 2007
Genus plc
Annual General Meeting
At the Annual General Meeting of Genus plc ('Genus') to be held today at 2.30pm,
the Chairman, John Hawkins, will make the following statement:
'During the financial year to 30 June 2007, the first full year since we
completed the Sygen acquisition that so dramatically changed the potential of
the Company, we have achieved strong business growth and increased cost
productivity by successfully integrating the acquired business. In the years to
come, Genus' progress will continue to benefit from the increased opportunities
arising from that acquisition.
In the Annual Report and Financial Statements for last year's trading, we
confirmed the Board's intention to divest the remaining non-core businesses to
drive down debt, while ensuring that such divestments would realise good
shareholder value. We also stated that we would continue to seek to increase
liquidity in Genus shares.
In these pursuits, in October, we completed the sale of the only remaining
shrimp business, SyAqua Mexico and last week, we announced the disposal of
HTSPE, the Development Consulting business.
To increase liquidity in Genus shares and to reduce debt, on 6 November, we
announced that we had raised £19.4m from placing 2.7 million shares with
institutions at £7.20 per share. This placing is expected to be earnings
enhancing as it reduces group debt to below £100m, thereby reducing the Group's
average interest costs by 25 basis points.
Also to improve liquidity, in parallel, we concluded a small shareholder buy-
back and placing with institutional shareholders, for a total of 1.15 million
shares at a price of up to £7.30 per share. 1,692 small shareholders in Genus
took advantage of this low cost dealing mechanism.
Trading for the new financial year has started well in the anticipated improving
agricultural climate. For the first quarter, trading has been on plan, despite
the weakening dollar. While we expect some uncertainty to continue in Europe,
as the industry adjusts to the challenges of a changing environment, buoyancy in
other markets should more than compensate for this.
The Board was delighted to announce, on 12 November, the admission of trading in
Genus' shares to the Official List of the London Stock Exchange. Genus was
originally formed when the Milk Marketing Board was privatised in 1994 and first
traded as a Public Company on OFEX in 1997, progressing to AIM in 2000. Now
with a Market Capitalisation of around £420m, Genus is ranked at about 350 of
the leading FTSE companies.
In closing my review, I would like to offer my thanks to my colleagues on the
Board for their support in our achievements, over the last 10 years, but
particularly for this year. With the Company's move to the Official List,
Edwin White, the Company's senior non-executive director, has indicated his
intention to leave the Board during the current financial year and the Company
is in the process of recruiting Mr White's successor.
I would also like to compliment the management team and the staff at Genus for
their achievements over this ten year period of considerable change and
development of the company.
The Board believes we have created a company with considerable market strength,
good R&D, proven skills in managing both organic and acquisition growth and
operating cost advantages from integrating the recent acquisition. This bodes
well for the future of Genus in improving market conditions.
To conclude, I would like to offer the Board's commitment to Genus' shareholders
that, as we begin a new chapter in the development of Genus as a Listed
Company, we will continue to build on the success that we have so far achieved.'
For further information please contact:
Genus plc Tel: 01256 347 100
Richard Wood, Chief Executive
Martin Boden, Finance Director
Landsbanki Securities (UK) Limited Tel: 020 7426 9000
Financial Advisor & Joint Broker
Shaun Dobson
Panmure Gordon (UK) Limited Tel: 020 7459 3600
Joint Broker
Mark Lander
Buchanan Communications Tel: 020 7466 5000
Charles Ryland
Suzanne Brocks
Christian Goodbody
This information is provided by RNS
The company news service from the London Stock Exchange